Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
phenotype | 0.100 | None | 1.000 | 5 | 3 | 2008 | 2017 | ||||||||
|
BBX high mobility group box domain containing | 0.839 | 0.231 | 0.52 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2009 | 2017 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2010 | 2019 | ||||||||
|
BDNF antisense RNA | 0.638 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2010 | 2019 | |||||||||
|
phosphodiesterase 1C | 0.700 | 0.423 | 5.4E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
egl-9 family hypoxia inducible factor 2 | 0.604 | 0.731 | 0.72 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
RAB4B-EGLN2 readthrough (NMD candidate) | 0.641 | 0.654 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | |||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
chromosome 1 open reading frame 100 | 1.3E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||||
|
thrombospondin type 1 domain containing 7B | 0.890 | 0.154 | 2.6E-19 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2015 | 2019 | ||||||||
|
IKAROS family zinc finger 4 | 0.861 | 0.192 | 0.90 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2015 | 2019 | ||||||||
|
leucine rich repeat and Ig domain containing 2 | 0.674 | 0.615 | 0.86 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2015 | 2017 | ||||||||
|
citrate lyase beta like | 0.743 | 0.500 | 1.6E-09 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2015 | 2019 | ||||||||
|
hydroxylysine kinase | 0.769 | 0.346 | 7.3E-06 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2015 | 2017 | ||||||||
|
contactin associated protein family member 4 | 0.839 | 0.192 | 7.8E-07 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2015 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 4 subunit | 0.492 | 0.808 | 8.5E-05 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2015 | 2018 | ||||||||
|
ubiquitin associated protein 2 | 0.729 | 0.385 | 3.4E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
CUGBP Elav-like family member 4 | 0.743 | 0.385 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 3 | 2015 | 2015 | ||||||||
|
PHD finger protein 8 | 0.631 | 0.577 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
mitochondrial ribosomal protein S22 | 0.638 | 0.500 | 1.5E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
matrix metallopeptidase 26 | 0.650 | 0.615 | 5.4E-11 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
KIAA1217 | 0.769 | 0.308 | 2.3E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
myosin XVI | 0.722 | 0.308 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
cyclin dependent kinase 19 | 0.691 | 0.462 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 | ||||||||
|
Rho GTPase activating protein 15 | 0.682 | 0.462 | 1.4E-08 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2015 | 2015 |